BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 4, 2026
Home » Authors » John Fox

Articles by John Fox

Progress made toward beating chronic viral infections

Aug. 10, 2016
By John Fox
HONG KONG – Two research teams have independently identified a specialized cytotoxic killer T-cell population and shown that boosting the number and killing ability of those cells may lead to an effective treatment for currently incurable lifelong viral infections, notably HIV.
Read More

Progress made toward beating chronic viral infections

Aug. 10, 2016
By John Fox
HONG KONG – Two research teams have independently identified a specialized cytotoxic killer T-cell population and shown that boosting the number and killing ability of those cells may lead to an effective treatment for currently incurable lifelong viral infections, notably HIV.
Read More

New technique offers gene editing without even cutting DNA

Aug. 9, 2016
By John Fox

New technique offers gene editing without cutting DNA

Aug. 8, 2016
By John Fox
HONG KONG – A modified version of the revolutionary gene-editing system known as clustered regularly interspaced short palindromic repeats – cellular apoptosis susceptibility protein (CRISPR/Cas), allows researchers to perform DNA substitutions without actually cleaving the DNA, according to a new Japanese study led by researchers at the University of Kobe.
Read More

Proteins acting as RNA-binders may point to new heart disease cure

Aug. 3, 2016
By John Fox
HONG KONG – A new study led by scientists at the Australian National University (ANU) has provided valuable insights into how the function of the human genome depends on RNA-binding proteins, an important discovery that could ultimately lead to the development of new treatments for heart disease.
Read More

Proteins acting as RNA-binders may point to new heart disease cure

Aug. 1, 2016
By John Fox
HONG KONG – A new study led by scientists at the Australian National University (ANU) has provided valuable insights into how the function of the human genome depends on RNA-binding proteins, an important discovery that could ultimately lead to the development of new treatments for heart disease.
Read More

Anti-parasitic drug shows potential for treating breast cancer

July 26, 2016
By John Fox

HONG KONG – The common anti-parasitic agent, ivermectin, may be a viable new option to treat breast cancer, reported Chinese researchers, who have demonstrated that it inhibited the proliferation of breast cancer cells and elucidated its mechanism of action in a new study.


Read More

Anti-parasitic drug shows potential for treating breast cancer

July 26, 2016
By John Fox
HONG KONG – The common anti-parasitic agent, ivermectin, may be a viable new option to treat breast cancer, reported Chinese researchers, who have demonstrated that it inhibited the proliferation of breast cancer cells and elucidated its mechanism of action in a new study.
Read More

Potential new target for candidiasis identified

July 20, 2016
By John Fox
HONG KONG – A collaborative study by U.S. and Chinese researchers has identified an immune system component responsible for the homeostatic control of innate immune responses to nosocomial invasive candidiasis, which represents a potential target that may lead to the development of treatments for the fungal infection.
Read More

Potential new target for candidiasis identified

July 20, 2016
By John Fox
HONG KONG – A collaborative study by U.S. and Chinese researchers has identified an immune system component responsible for the homeostatic control of innate immune responses to nosocomial invasive candidiasis, which represents a potential target that may lead to the development of treatments for the fungal infection.
Read More
Previous 1 2 … 43 44 45 46 47 48 49 50 51 … 68 69 Next

Popular Stories

  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • Nerves within a melanoma tumor

    Innervation can slow, as well as speed, tumor growth, study finds

    BioWorld
    Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
  • Alceptor Therapeutics discovers new α2B-adrenoceptor agonists

    BioWorld Science
    Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing